Molecular Psychiatry

Article	Citations
Integration of valence and conflict processing through cellular-field interactions in human subgenual cingulate during emotional face processing in treatment-resistant depression	557
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings	468
Multi-polygenic score prediction of mathematics, reading, and language abilities independent of general cognitive ability	428
Crif1 deficiency in dopamine neurons triggers early-onset parkinsonism	376
Correction: Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pa	315
Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility	286
Crosstalk between alcohol use disorder and obesity: two sides of the same coin?	284
Microbial infection promotes amyloid pathology in a mouse model of Alzheimer’s disease via modulating γ-secretase	248
Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B and related neuropeptide transmitter signatures	216
Rare tandem repeat expansions associate with genes involved in synaptic and neuronal signaling functions in schizophrenia	195
Tractography-based versus anatomical landmark-based targeting in vALIC deep brain stimulation for refractory obsessive-compulsive disorder	181
Microglia shape AgRP neuron postnatal development via regulating perineuronal net plasticity	171
Interrelations between dopaminergic-, gabaergic- and glutamatergic neurotransmitters in antipsychotic-naïve psychosis patients and the association to initial treatment response	169
Neurobiological subtypes of adolescent depression: a multimodal integration of morphometric similarity network and spatial transcriptomics	162
Maternal stressors disrupt mouse placental proteome and fetal brain development in a sex-specific fashion through inflammation and oxidative stress	154
Disease clusters and their genetic determinants following a diagnosis of depression: analyses based on a novel three-dimensional disease network approach	149
Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome	146
Rare coding variants as risk modifiers of the 22q11.2 deletion implicate postnatal cortical development in syndromic schizophrenia	143
The role of PPAR-γ in memory deficits induced by prenatal and lactation alcohol exposure in mice	140
Multivariate patterns linking brain microstructure to temperament and behavior in adolescent eating disorders	131
The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder	128
Both GEF domains of the autism and developmental epileptic encephalopathy-associated Trio protein are required for proper tangential migration of GABAergic interneurons	126
Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces hyperarousal and enhanced cognition but impaired inhibitory control	122
MYT1L haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic intervention	121
Neurocognitive effects of stress: a metaparadigm perspective	118

Roles of the medial and lateral orbitofrontal cortex in major depression and its treatment	117
Melatonin: A potential nighttime guardian against Alzheimer’s	117
Transcriptomic and epigenomic consequences of heterozygous loss-of-function mutations in AKAP11, a shared risk gene for bipolar disorder and schizophrenia	116
Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters	113
Positive modulation of N-methyl-D-aspartate receptors in the mPFC reduces the spontaneous recovery of fear	112
Loss of Necdin causes social deficit and aberrant synaptic function through destabilization of SynGAP	110
Quantitative magnetization transfer and g-ratio imaging of white matter myelin in early psychotic spectrum disorders	110
Hyperactivity of subicular parvalbumin interneurons drives early amyloid pathology and cognitive deficits in Alzheimer’s disease	110
Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer’s disease through potentiating the function of extrasynaptic glycine receptors	110
Mitochondrial health index correlates with plasma circulating cell-free mitochondrial DNA in bipolar disorder	105
Deciphering the influence of socioeconomic status on brain structure: insights from Mendelian randomization	104
The role of polyunsaturated fatty acids in the neurobiology of major depressive disorder and suicide risk	104
CLN5 deficiency impairs glucose uptake and uncovers PHGDH as a potential biomarker in Batten disease	101
Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner	100
The alpha7 nicotinic acetylcholine receptor mediates network dysfunction in a mouse model of local amyloid pathology	100
Mediating and moderating effects of plasma proteomic biomarkers on the association between poor oral health problems and brain white matter microstructural integrity: the UK Biobank study	99
Shared genetic basis between reproductive behaviors and anxiety-related disorders	98
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders	97
Sex differences in trajectories of cortical development in autistic children from 2–13 years of age	95
Maternal COVID-19 infection associated with offspring neurodevelopmental disorders	95
Transcriptomic pathology of neocortical microcircuit cell types across psychiatric disorders	95
Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders	94
Stress-induced dysfunction of neurovascular astrocytes in the prefrontal cortex contributes to sex-dependent deficits in cognition and behavior	92
Rare copy number variation in posttraumatic stress disorder	92
Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample	92
Age-related vulnerability of the human brain connectome	92
5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA	90
Transcriptome and chromatin alterations in social fear indicate association of MEG3 with successful extinction of fear	89
Electric field distribution models in ECT research	89
A burden of rare copy number variants in obsessive-compulsive disorder	89
Activation of β2-adrenergic receptors prevents AD-type synaptotoxicity via epigenetic mechanisms	88
Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation	86
Psychedelics, psychosis, and the elusive notion of safety	86
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis	86
Unconsidered issues of measurement noninvariance in biological psychiatry: A focus on biological phenotypes of psychopathology	86
Insulin-like growth factor I mitigates post-traumatic stress by inhibiting AMP-kinase in orexin neurons	85
Aberrant impulse control circuitry in obesity	85
Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice	85
Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study	85
Structure-function relationships of the disease-linked A218T oxytocin receptor variant	84
Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory	83
Widespread choroid plexus contamination in sampling and profiling of brain tissue	81
Internal capsule microstructure mediates the relationship between childhood maltreatment and PTSD following adulthood trauma exposure	81
What genes are differentially expressed in individuals with schizophrenia? A systematic review	81
A genetic common factor underlying self-reported math ability and highest math class taken	80
Thalamo-frontal functional connectivity patterns in Tourette Syndrome: Insights from combined intracranial DBS and EEG recordings	78
Are behavioural and inflammatory profiles different according to type of stressor, developmental stage, and sex in rodent models of depression? A systematic review	77
Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists	77
Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems	77
An ace in the hole? Opportunities and limits of using mice to understand schizophrenia neurobiology	76

Mettl3 regulates the pathogenesis of Alzheimer’s disease via fine-tuning Lingo2	74
Schizophrenia-derived hiPSC brain microvascular endothelial-like cells show impairments in angiogenesis and blood–brain barrier function	73
Replication of a neuroimaging biomarker for striatal dysfunction in psychosis	73
The nested hierarchical model of self and its non-relational vs relational posttraumatic manifestation: an fMRI meta-analysis of emotional processing	72
11C-UCB-J PET imaging is consistent with lower synaptic density in autistic adults	72
Robust and replicable functional brain signatures of 22q11.2 deletion syndrome and associated psychosis: a deep neural network-based multi-cohort study	72
Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome	72
Noradrenergic modulation of glymphatic clearance: implications for neuropsychiatric disorders and mortality	71
The role of TSC1 and TSC2 proteins in neuronal axons	69
A higher dysregulation burden of brain DNA methylation in female patients implicated in the sex bias of Schizophrenia	69
Diverging asymmetry of intrinsic functional organization in autism	69
Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis	68
Deep learning algorithms reveal genomic markers for anxiety disorder in a large cohort of children with down syndrome	67
Bcl11a deficiency in cerebellar Purkinje cells causes ataxia and autistic-like behavior by altering Vav3	67
A meta-analysis of genome-wide studies of resilience in the German population	67
Neurodevelopmental model of schizophrenia revisited: similarity in individual deviation and idiosyncrasy from the normative model of whole-brain white matter tracts and shared brain-cognition covariat	67
Systematic reduction of gray matter volume in anorexia nervosa, but relative enlargement with clinical symptoms in the prefrontal and posterior insular cortices: a multicenter neuroimaging study	65
Heavy adolescent drinking makes the adult brain more vulnerable to ethanol by permanently altering the age-dependent interplay between alcohol, GIRK channels and activin	65
Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder	65
Monosynaptic rabies tracing maps inputs to CA1 cells in old AD model mice (APP-KI)	65
Advances in chemogenetics: a review of DREADDs and its application in psychiatric disorders	64
Parvalbumin interneurons gate amygdala excitability and response to chronic stress via kainate receptor-driven tonic GABAB receptor-mediated inhibition	64
The default network is causally linked to creative thinking	64
Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression	63
Fast-spiking parvalbumin-positive interneurons in brain physiology and Alzheimer’s disease	62
Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy	62
The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failure	61
Melancholia as psychalgia: the integration of psychophysiological theory and psychopathologic observation in the mid-19th century	61
Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes	60
Genome-wide meta-analyses of cross substance use disorders in diverse populations	60
Early-life microbiota dysbiosis as a link between Autism Spectrum Disorder and Parkinson’s Disease	59
Prenatal exposure to common plasticizers: a longitudinal study on phthalates, brain volumetric measures, and IQ in youth	59
Differential associations of adolescent versus young adult cannabis initiation with longitudinal brain change and behavior	59
Tbx1, a gene encoded in 22q11.2 copy number variant, is a link between alterations in fimbria myelination and cognitive speed in mice	58
Paternal nicotine taking elicits heritable sex-specific phenotypes that are mediated by hippocampal Satb2	58
Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk	57
De novo protein-coding gene variants in developmental stuttering	57
Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms	56
Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer’s disease	56
Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties	56
Differential impacts of germline and adult aggrecan knockout in PV+ neurons on perineuronal nets and PV+ neuronal function	55
Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone	55
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis	55
Application of deep learning algorithm on whole genome sequencing data uncovers structural variants associated with multiple mental disorders in African American patients	54
Neuroimmune contributions to Alzheimer’s disease: a focus on human data	54
Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry	54
The genetic basis of major depressive disorder	53
The amygdala NT3-TrkC pathway underlies inter-individual differences in fear extinction and related synaptic plasticity	53
Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer’s disease astrocytes	53
Suicidal behavior across a broad range of psychiatric disorders	53
Shared and unique transcriptomic signatures of antidepressant and probiotics action in the mammalian brain	53
Neocortical tau propagation is a mediator of clinical heterogeneity in Alzheimer’s disease	53
Glucocorticoid-glucocorticoid receptor-HCN1 channels reduce neuronal excitability in dorsal hippocampal CA1 neurons	52
Key subphenotypes of bipolar disorder are differentially associated with polygenic liabilities for bipolar disorder, schizophrenia, and major depressive disorder	52
Retraction Note: VPS35 regulates tau phosphorylation and neuropathology in tauopathy	52
Right frontal cingulate cortex mediates the effect of prenatal complications on youth internalizing behaviors	52
Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation	52
Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders	52
Investigating the impact of severe maternal SARS-CoV-2 infection on infant DNA methylation and neurodevelopment	51
The glymphatic system’s role in traumatic brain injury-related neurodegeneration	51
The dopaminergic basis of negative symptoms in schizophrenia: an addendum	51
Lineage specification into GABAergic, glutamatergic, dopaminergic, and astrocytic phenotypes using MUSE stem cells: a novel approach for modeling neurodegenerative and psychiatric disorders	51
A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease	51
Stress-induced changes of the cholinergic circuitry promote retrieval-based generalization of aversive memories	51
Atypical antipsychotics antagonize GABAA receptors in the ventral tegmental area GABA neurons to relieve psychotic behaviors	50
The need for youth psychiatry fellowship: a physician-scientist trainee perspective	50
Intergenerational transmission of complex traits and the offspring methylome	50
Letter to the editor: Comments on - Regulation of habenular G-protein gamma 8 on learning and memory via modulation of the central acetylcholine system	50
The genetics of severe depression	50
Predicting the future of neuroimaging predictive models in mental health	49
Social isolation reinforces aging-related behavioral inflexibility by promoting neuronal necroptosis in basolateral amygdala	49
Adaptor protein complex 2 in the orbitofrontal cortex predicts alcohol use disorder	49
Impaired functional connectivity of the hippocampus in translational murine models of NMDA-receptor antibody associated neuropsychiatric pathology	49
Absent LH signaling rescues the anxiety phenotype in aging female mice	49
Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020–2022	48
Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and m	48
The neuroendocrinology of stress and the importance of a proper balance between the mineralocorticoid and glucocorticoid receptors	48
Circulating metabolites modulated by diet are associated with depression	47
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex	47
Evidence of bidirectional relationship between type 2 diabetes and depression; a Mendelian randomization study	47

A neurometabolic mechanism involving dmPFC/dACC lactate in physical effort-based decision-making	47
Mutations in trpγ, the homologue of TRPC6 autism candidate gene, causes autism-like behavioral deficits in Drosophila	46
Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology	46
Systemic medications and dementia risk: a systematic umbrella review	46
Ketamine: anesthetic, psychotomimetic, antidepressant, or anthelmintic?	46
Early postnatal dysfunction of ACC PV interneurons in Shank3B−/− mice	46
Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals	46
Potential sensitive period effects of maltreatment on amygdala, hippocampal and cortical response to threat	46
Rasd2 regulates depression-like behaviors via DRD2 neurons in the prelimbic cortex afferent to nucleus accumbens core circuit	45
Gut microbiome predicts cognitive function and depressive symptoms in late life	45
Inhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in vivo	45
Perturbed iron biology in the prefrontal cortex of people with schizophrenia	45
Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3	44
Sleep spindle architecture associated with distinct clinical phenotypes in older adults at risk for dementia	44
Translational research approach to social orienting deficits in autism: the role of superior colliculus-ventral tegmental pathway	44
Prenatal THC exposure induces long-term, sex-dependent cognitive dysfunction associated with lipidomic and neuronal pathology in the prefrontal cortex-hippocampal network	43
AI and the coming mental health zombie apocalypse	43
Overexpression of transmembrane TNFα in brain endothelial cells induces schizophrenia-relevant behaviors	43
Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk	43
Genome-wide analysis identifies novel loci influencing plasma apolipoprotein E concentration and Alzheimer’s disease risk	43
Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study	42
Epigenomic signatures reveal mechanistic clues and predictive markers for autism spectrum disorder	42
Diet and depression: future needs to unlock the potential	42
Microglia-containing human brain organoids for the study of brain development and pathology	42
Correction: On the proportion of patients who experience a prodrome prior to psychosis onset: a systematic review and meta-analysis	41
PsycGM: a comprehensive database for associations between gut microbiota and psychiatric disorders	41
The extracellular matrix and perineuronal nets in memory	41
Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’”	41
Gut microbiota regulate insomnia-like behaviors via gut-brain metabolic axis	41
CRISPRi-based screen of autism spectrum disorder risk genes in microglia uncovers roles of ADNP in microglia endocytosis and synaptic pruning	41
Tempering an interpretation based on quality of data to make causal conclusions about race, inequities, and brain differences	41
Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium	41
Molecular pathways of major depressive disorder converge on the synapse	41
Differential impact of cerebral small vessel disease on thalamic regulation of anxiety: insights from 7T MRI	40
Differential effects of lithium on metabolic dysfunctions in astrocytes derived from bipolar disorder patients	40
Comments to behavioral tests for antidepressant-like actions of (2R,6R)–hydroxynorketamine by Bonaventura et al.	40
A midbrain-reticulotegmental circuit underlies exaggerated startle under fear emotions	40
Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach	40
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis	40
Characterization of transcriptional profiles associated with stress-induced neuronal activation in Arc-GFP mice	40
Correction to: Elevated maternal C-reactive protein and autism in a national birth cohort	40
Ventral tegmental area glutamate neurons mediate nonassociative consequences of stress	40
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia	40
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation	39
Pathogenic TRIO variants associated with neurodevelopmental disorders perturb the molecular regulation of TRIO and axon pathfinding in vivo	39
A short period of early life oxytocin treatment rescues social behavior dysfunction via suppression of hippocampal hyperactivity in male mice	39
BNIP3L/NIX-mediated mitophagy alleviates passive stress-coping behaviors induced by tumor necrosis factor-α	39
Admixture Mapping of Alzheimer’s disease in Caribbean Hispanics identifies a new locus on 22q13.1	39
TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKIIα activity in the NAc	39
CB1 receptors on a subset of vagal afferent neurons modulate voluntary ethanol intake in mice	39
Attention and executive delays in early childhood: a meta-analysis of neurodevelopmental conditions	39
Evidence of a large current of transcranial alternating current stimulation directly to deep brain regions	39
Stress induces behavioral disorders by promoting microglial phagocytosis via decreasing neuronal Dkk3	39
Genetic regulation of human brain proteome reveals proteins implicated in psychiatric disorders	38
Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes	38
Tau suppresses microtubule-regulated pancreatic insulin secretion	38
Seed-induced Aβ deposition alters neuronal function and impairs olfaction in a mouse model of Alzheimer’s disease	38
Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania	38
Structural deficits in key domains of Shank2 lead to alterations in postsynaptic nanoclusters and to a neurodevelopmental disorder in humans	38
Validation of plasma protein glycation and oxidation biomarkers for the diagnosis of autism	38
Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia	38
Traumatic stress load and stressor reactivity score associated with accelerated gray matter maturation in youths indexed by normative models	37
Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches	37
Hypoxia Inducible Factor-1α binds and activates γ-secretase for Aβ production under hypoxia and cerebral hypoperfusion	37
Correction: Arc controls alcohol cue relapse by a central amygdala mechanism	37
Long COVID: plasma levels of neurofilament light chain in mild COVID-19 patients with neurocognitive symptoms	37
Hippocampal neuroplasticity, major depression and, not to forget: ECT	37
Targeting metaplasticity mechanisms to promote sustained antidepressant actions	37
The number of episodes of major psychiatric and substance use disorders as an index of genetic risk and genetic heterogeneity	36
The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. “Burning down the house: reinventing drug discovery in psychiatry for the d	36
Neural circuit mechanisms underlying aberrantly prolonged functional hyperemia in young Alzheimer’s disease mice	36
Lifetime depression and mania/hypomania risk predicted by neural markers in three independent young adult samples during working memory and emotional regulation	36
Re: Berding K, Bastiaanssen TFS, Moloney GM, Boscaini S, Strain CR, Anesi A, Long-Smith C, Mattivi F, Stanton C, Clarke G, Dinan TG, Cryan JF. Feed your microbes to deal with stress: a psychobiotic di	36
Predominance of visuoconstructive impairment after mild COVID-19?	36
Reply to “Concerns regarding the interpretation of Shank3 protein isoforms expressed in Shank3B−/− mice: potential off-target effects by a neomycin resistance cassette”	36
Chemogenetic manipulation of CX3CR1+ cells transiently induces hypolocomotion independent of microglia	36
Cerebral organoids with chromosome 21 trisomy secrete Alzheimer’s disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy	35
Dose mediates the protracted effects of adolescent THC exposure on reward and stress reactivity in males relevant to perturbation of the basolateral amygdala transcriptome	35
The NMDAR/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer’s disease	35
Unraveling the associations between voice pitch and major depressive disorder: a multisite genetic study	35
Methylome-wide association study of antidepressant use in Generation Scotland and the Netherlands Twin Register implicates the innate immune system	35
Genetically regulated multi-omics study for symptom clusters of posttraumatic stress disorder highlights pleiotropy with hematologic and cardio-metabolic traits	34
Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia	34
Dysfunctional serotonergic neuron-astrocyte signaling in depressive-like states	34
Epitranscriptomic dynamics in brain development and disease	34
RNA alternative splicing impacts the risk for alcohol use disorder	34
Morphometric dis-similarity between cortical and subcortical areas underlies cognitive function and psychiatric symptomatology: a preadolescence study from ABCD	34
Glutamatergic synapse in autism: a complex story for a complex disorder	34
Retraction Note to: Full recovery of the Alzheimer’s disease phenotype by gain of function of vacuolar protein sorting 35	34
Prenatal and early childhood infections requiring hospitalization and risk of neurodevelopmental disorders in offspring: a population-based birth cohort study in Taiwan	34
Delta opioid receptor agonists activate PI3K–mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects	34
A three-dimensional model of neural activity and phenomenal-behavioral patterns	34
Mapping the neurodevelopmental predictors of psychopathology	34
Adaptive changes to oxidative stress in schizophrenia	33
Decreased basal ganglia and thalamic iron in early psychotic spectrum disorders are associated with increased psychotic and schizotypal symptoms	33